These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 376087)

  • 1. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
    Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
    Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
    Jaffe ES; Strauchen JA; Berard CW
    Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphoblastic lymphoma/leukemia with convoluted nuclei: the question of its relation to the T-cell lineage studied in 13 patients.
    Boucheix C; Diebold J; Bernadou A; Reynes M; Tulliez M; Cadiou M; Paczynski V; Capron F; Bilski-Pasquier G
    Cancer; 1980 Apr; 45(7):1569-77. PubMed ID: 6966181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.